143 related articles for article (PubMed ID: 27109639)
21. Germline CBM-opathies: From immunodeficiency to atopy.
Lu HY; Biggs CM; Blanchard-Rohner G; Fung SY; Sharma M; Turvey SE
J Allergy Clin Immunol; 2019 May; 143(5):1661-1673. PubMed ID: 31060714
[TBL] [Abstract][Full Text] [Related]
22. Ubiquitination for activation: new directions in the NF-kappaB roadmap.
Lynch OT; Gadina M
Mol Interv; 2004 Jun; 4(3):144-6. PubMed ID: 15210867
[TBL] [Abstract][Full Text] [Related]
23. MALT1-ubiquitination triggers non-genomic NF-κB/IKK signaling upon platelet activation.
Karim ZA; Vemana HP; Khasawneh FT
PLoS One; 2015; 10(3):e0119363. PubMed ID: 25748427
[TBL] [Abstract][Full Text] [Related]
24. Detection of recombinant and cellular MALT1 paracaspase activity.
Nagel D; Krappmann D
Methods Mol Biol; 2015; 1280():239-46. PubMed ID: 25736752
[TBL] [Abstract][Full Text] [Related]
25. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
Wegener E; Krappmann D
Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
[TBL] [Abstract][Full Text] [Related]
26. Detection and measurement of paracaspase MALT1 activity.
Hailfinger S; Pelzer C; Thome M
Methods Mol Biol; 2014; 1133():177-88. PubMed ID: 24567102
[TBL] [Abstract][Full Text] [Related]
27. Paracaspase MALT1 deficiency protects mice from autoimmune-mediated demyelination.
Mc Guire C; Wieghofer P; Elton L; Muylaert D; Prinz M; Beyaert R; van Loo G
J Immunol; 2013 Mar; 190(6):2896-903. PubMed ID: 23401595
[TBL] [Abstract][Full Text] [Related]
28. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20.
Coornaert B; Baens M; Heyninck K; Bekaert T; Haegman M; Staal J; Sun L; Chen ZJ; Marynen P; Beyaert R
Nat Immunol; 2008 Mar; 9(3):263-71. PubMed ID: 18223652
[TBL] [Abstract][Full Text] [Related]
29. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation.
Lee KY; D'Acquisto F; Hayden MS; Shim JH; Ghosh S
Science; 2005 Apr; 308(5718):114-8. PubMed ID: 15802604
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL.
Nagel D; Spranger S; Vincendeau M; Grau M; Raffegerst S; Kloo B; Hlahla D; Neuenschwander M; Peter von Kries J; Hadian K; Dörken B; Lenz P; Lenz G; Schendel DJ; Krappmann D
Cancer Cell; 2012 Dec; 22(6):825-37. PubMed ID: 23238017
[TBL] [Abstract][Full Text] [Related]
31. Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase.
Ruefli-Brasse AA; French DM; Dixit VM
Science; 2003 Nov; 302(5650):1581-4. PubMed ID: 14576442
[TBL] [Abstract][Full Text] [Related]
32. Requirement for caspase-8 in NF-kappaB activation by antigen receptor.
Su H; Bidère N; Zheng L; Cubre A; Sakai K; Dale J; Salmena L; Hakem R; Straus S; Lenardo M
Science; 2005 Mar; 307(5714):1465-8. PubMed ID: 15746428
[TBL] [Abstract][Full Text] [Related]
33. The paracaspase MALT1 dampens NF-κB signalling by cleaving the LUBAC subunit HOIL-1.
Hailfinger S; Schmitt A; Schulze-Osthoff K
FEBS J; 2016 Feb; 283(3):400-2. PubMed ID: 26716947
[No Abstract] [Full Text] [Related]
34. Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity.
Torres JM; Martinez-Barricarte R; García-Gómez S; Mazariegos MS; Itan Y; Boisson B; Rholvarez R; Jiménez-Reinoso A; del Pino L; Rodríguez-Pena R; Ferreira A; Hernández-Jiménez E; Toledano V; Cubillos-Zapata C; Díaz-Almirón M; López-Collazo E; Unzueta-Roch JL; Sánchez-Ramón S; Regueiro JR; López-Granados E; Casanova JL; Pérez de Diego R
J Clin Invest; 2014 Dec; 124(12):5239-48. PubMed ID: 25365219
[TBL] [Abstract][Full Text] [Related]
35. Bcl10 and Malt1 control lysophosphatidic acid-induced NF-kappaB activation and cytokine production.
Klemm S; Zimmermann S; Peschel C; Mak TW; Ruland J
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):134-8. PubMed ID: 17095601
[TBL] [Abstract][Full Text] [Related]
36. Human IκBα Gain of Function: a Severe and Syndromic Immunodeficiency.
Boisson B; Puel A; Picard C; Casanova JL
J Clin Immunol; 2017 Jul; 37(5):397-412. PubMed ID: 28597146
[TBL] [Abstract][Full Text] [Related]
37. Protease activity of MALT1: a mystery unravelled.
Kirchhofer D; Vucic D
Biochem J; 2012 Jun; 444(2):e3-5. PubMed ID: 22574776
[TBL] [Abstract][Full Text] [Related]
38. A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency.
Jabara HH; Ohsumi T; Chou J; Massaad MJ; Benson H; Megarbane A; Chouery E; Mikhael R; Gorka O; Gewies A; Portales P; Nakayama T; Hosokawa H; Revy P; Herrod H; Le Deist F; Lefranc G; Ruland J; Geha RS
J Allergy Clin Immunol; 2013 Jul; 132(1):151-8. PubMed ID: 23727036
[TBL] [Abstract][Full Text] [Related]
39. Actin polymerisation after FCγR stimulation of human fibroblasts is BCL10 independent.
Garcia-Gomez S; Alvarez Doforno R; Martinez-Barricarte R; Torres JM; Ferreira Cerdan A; Davila M; Hernández-Jiménez E; Toledano V; Cubillos-Zapata C; Vallejo-Cremades MT; López-Collazo E; Fernández Arquero M; Sánchez-Ramón S; Casanova JL; Pérez de Diego R
Clin Immunol; 2016 Feb; 163():120-2. PubMed ID: 26774590
[TBL] [Abstract][Full Text] [Related]
40. Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen.
Boztug H; Karitnig-Weiß C; Ausserer B; Renner ED; Albert MH; Sawalle-Belohradsky J; Belohradsky BH; Mann G; Horcher E; Rümmele-Waibel A; Geyeregger R; Lakatos K; Peters C; Lawitschka A; Matthes-Martin S
Pediatr Hematol Oncol; 2012 Oct; 29(7):585-94. PubMed ID: 22897717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
